Form 4 for ACRS Aclaris Therapeutics, Inc.
Accepted 2021-07-07 00:00:00 ET · period of report 2021-07-02 · accession 0001209191-21-045899 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-07-07 | 2021-07-02 | ACRS | Gordon David N. | Chief Medical Off | M - OptEx | — | +6,000 | 150.1K | +4% | — |
| D | 2021-07-07 | 2021-07-02 | ACRS | Gordon David N. | Chief Medical Off | M - OptEx | $0.00 | -6,000 | 6,000 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-02 | M | A | 6,000 | — | 150,078 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. |
| 2 | Derivative | Restricted Stock Units | 2021-07-02 | M | D | 6,000 | $0.00 | 6,000 | D | — · — to — | 6,000 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer. (F2) The shares underlying these restricted stock units vest over a period of four years, with 25% vesting on the first, second, third and fourth anniversaries of the date of grant, beginning on July 2, 2019 and subject to the reporting person's continuous service with the issuer as of the applicable vesting date. |